HOME > TOP STORIES
TOP STORIES
-
BUSINESS Kobayashi Kako Chief to Resign over Drug Mix-Up, Lousy Manufacturing and Cover-Ups
February 10, 2021
-
REGULATORY Kobayashi Kako Slapped with Record 116-Day Business Suspension
February 9, 2021
-
REGULATORY Pfizer’s COVID-19 Shot Up for PAFSC Review Feb. 12, Kono Expects Govt to Secure Enough Doses for 1st-in-Line HCPs
February 9, 2021
-
BUSINESS 7 Japan Drug Majors See 2.7% Revenue Fall in FY2020, COVID-19 Forces Cuts on Guidance: Jiho Tally
February 8, 2021
-
BUSINESS Health Minister Hails Domestic Production Plan for AstraZeneca Vaccine
February 8, 2021
-
BUSINESS AstraZeneca Files COVID-19 Vaccine in Japan
February 5, 2021
-
BUSINESS MSD to Launch Silgard 9 on Feb. 24, but Mass Supply in Japan Unlikely Until 2023
February 5, 2021
-
BUSINESS Gilead Mulling Japan Entry into PIII Study for Inhaled Version of Veklury
February 5, 2021
-
BUSINESS Drug Makers Moving to Discontinue Ranitidine/Nizatidine Products over Carcinogen Issue
February 4, 2021
-
REGULATORY Celgene’s Liso-Cel Up for PAFSC Review on Feb. 17, 3rd CAR-T Therapy in Japan
February 4, 2021
-
BUSINESS Eisai Neurology Chief Says Partners Continue to Stand Behind Aducanumab
February 4, 2021
-
ORGANIZATION PhRMA Prods Japan to Harness Power of RWD in Drug Development, Medical Care Evaluation
February 3, 2021
-
REGULATORY Japan Moves Up Vaccine Rollout Target to Mid-February, PAFSC Review on Feb. 12?
February 3, 2021
-
INTERVIEW Alzheimer’s Treatment at Crossroads? Top Expert on AD Research, Aducanumab and Its Implications - 1
February 2, 2021
-
BUSINESS Teijin to Acquire Fujifilm's J-TEC for Up to 21.6 Billion Yen
February 1, 2021
-
BUSINESS FDA Delays Decision for Biogen’s Aducanumab to June 7
February 1, 2021
-
REGULATORY MHLW Wants to Encourage Non-Monitoring Facilities to Report Inappropriate Drug Promotion
January 29, 2021
-
BUSINESS Kobayashi Kako Issues Yet Another Recall, Now for 12 APIs/21 Products
January 28, 2021
-
REGULATORY Kobayashi Kako Might Face 116-Day Biz Suspension over Drug Mix-Up
January 27, 2021
-
REGULATORY Kobayashi Kako Notified of Record Biz Suspension of 110-Plus Days over Drug Mix-Up
January 26, 2021
ページ
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
